Welcome to LookChem.com Sign In|Join Free
  • or
N-(4-methyl-cyclohex-3-enyl)-phthalimide is a chemical compound with the molecular formula C15H15NO2. It features a phthalimide core, which is a cyclic imide derived from phthalic anhydride, and a 4-methyl-cyclohex-3-enyl group attached to the nitrogen atom. N-(4-methyl-cyclohex-3-enyl)-phthalimide is characterized by its aromatic structure and the presence of a methyl group on the cyclohexene ring, which contributes to its unique chemical properties. It is often used in organic synthesis and as an intermediate in the production of various pharmaceuticals and specialty chemicals. The compound's structure provides it with potential applications in materials science and as a precursor in the synthesis of more complex molecules.

25577-22-4

Post Buying Request

25577-22-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

25577-22-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 25577-22-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,5,7 and 7 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 25577-22:
(7*2)+(6*5)+(5*5)+(4*7)+(3*7)+(2*2)+(1*2)=124
124 % 10 = 4
So 25577-22-4 is a valid CAS Registry Number.

25577-22-4Relevant academic research and scientific papers

SOLID FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE, COMPOSITIONS THEREOF AND METHODS OF THEIR USE

-

Paragraph 00461, (2015/11/02)

Provided herein are formulations, processes, solid forms and methods of use relating to 2- (tert-butylamino)-4-((lR,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5- carboxamide.

SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE PYRIMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

-

, (2012/11/07)

Provided herein are Diaminopyrimidine Compounds having the following structures: wherein R1, R2, R3, and R4 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidine Compound, and methods for treating or preventing liver fibrotic disorders or a condition treatable or preventable by inhibition of a JNK pathway.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 25577-22-4